A detailed history of Aspire Private Capital, LLC transactions in Viatris Inc stock. As of the latest transaction made, Aspire Private Capital, LLC holds 334 shares of VTRS stock, worth $3,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares
334
Previous 344 2.91%
Holding current value
$3,857
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$10.05 - $12.02 $100 - $120
-10 Reduced 2.91%
334 $3,000
Q1 2024

Apr 18, 2024

BUY
$11.27 - $13.53 $112 - $135
10 Added 2.99%
344 $4,000
Q4 2023

Feb 01, 2024

BUY
$8.77 - $10.85 $1,754 - $2,170
200 Added 149.25%
334 $3,000
Q1 2022

May 10, 2022

SELL
$9.81 - $15.4 $9 - $15
-1 Reduced 0.74%
134 $1,000
Q1 2021

May 26, 2021

BUY
$13.59 - $18.54 $1,834 - $2,502
135 New
135 $2,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.